An isolated nucleic acid molecule, a fusion polypeptide, expression vector, a method of producing a VEGF fusion polypeptide, growth factor pickup vascular endothelial cell, pharmaceutical composition, method of treating a disease or condition that are restored, enhanced or inhibited by removal or inhibition of vascular endothelial growth factor, and article of manufacture

"Acid molecule NUCLEIC ISOLATED, a fusion polypeptide, EXPRESSION VECTOR, PRODUCING METHOD A polypeptide OF VEGF fusion PICKUP cell ENDOTHELIAL VASCULAR GROWTH FACTOR, PHARMACEUTICAL COMPOSITION, TREATING METHOD a disease or condition WHAT are restored, IMPROVED OR INHIBITED BY rEMOVING OR ENDOTHELIAL GROWTH FACTOR VASCULAR inhibition, E, ARTICLE mANUFACTURING ". Nucleic acid molecules and multimeric proteins capable of binding vascular endothelial growth factor (VEGF). VEGF scavengers are disclosed which are therapeutically useful for treating conditions and diseases associated with VEGF and are specifically designed for local administration to organs, tissues and / or cell specific.